home / stock / hepa / hepa news

HEPA News and Press, Hepion Pharmaceuticals Inc. From 11/12/20

Stock Information
Company Name: Hepion Pharmaceuticals Inc.
Stock Symbol: HEPA
Market: NASDAQ
Website: hepionpharma.com
Menu
HEPA HEPA Quote HEPA Short HEPA News HEPA Articles HEPA Message Board
Get HEPA Alerts

News, Short Squeeze, Breakout and More Instantly...
HEPA - Hepion Pharmaceuticals to Present at The Liver Meeting Digital Experience(TM) 2020

EDISON, NJ / ACCESSWIRE / November 12, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis ("NASH"), today announced tha...
HEPA - Hepion Pharmaceuticals Completes First Cohort Enrollment in Phase 2a 'AMBITION' Clinical Trial

EDISON, NJ / ACCESSWIRE / November 10, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis ("NASH"), today announced tha...

HEPA - Hepion Pharmaceuticals to Present on Therapeutic Approaches to COVID-19 and NASH at Two Virtual Conferences on October 28 and 29, 2020

EDISON, NJ / ACCESSWIRE / October 27, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company developing the drug candidate, CRV431, today announced that it will present virtually at the Roth Capital Healthcare Therapeutic Approaches for COVID-19 eve...

HEPA - Hepion announces A.I. platform for drug development

Hepion Pharmaceuticals ([[HEPA]] +1.9%) has rolled out a proprietary artificial intelligence ((AI)), machine learning platform called, AI-POWR, with an aim to identify responders a priori and reduce the need for large sample sizes through study design enrichment.The components of AI...
HEPA - Hepion Pharmaceuticals Introduces Proprietary A.I. Platform for Drug Development & Announces Creation of Clinical Pharmacology Analytics Team

AI-POWR ™ Driving Big Data Analytics EDISON, NJ / ACCESSWIRE / October 5, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)("Hepion"), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising fro...

HEPA - Hepion Pharmaceuticals to Present at H.C. Wainwright's 4th Annual NASH Virtual Investor Conference

EDISON, NJ / ACCESSWIRE / September 29, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis ("NASH"), today announced that Dr. Robert Fos...

HEPA - SRNE, IMGN among premarket gainers

Sorrento Therapeutics (NASDAQ: SRNE )   +30%  on FDA nod for early-stage COVID-19 antibody trial. More news on: Sorrento Therapeutics, Inc., Hepion Pharmaceuticals, Inc., Vaccinex, Inc., , Stocks on the move, Read more ...

HEPA - Hepion's lead drug shows antiviral activity against COVID-19

Hepion Pharmaceuticals (NASDAQ: HEPA ) jumped  ~11%  in premarket in reaction to positive data from a study of CRV431 conducted by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH). More news on: Hepion Pharmaceuti...

HEPA - Hepion Pharmaceuticals Reports Positive Activity of CRV431 Against Coronavirus SARS-2 in Study Conducted by the National Institute of Allergy and Infectious Diseases

EDISON, NJ / ACCESSWIRE / September 17, 2020 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)("Hepion"), a biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis ("NASH"), today announced that a st...

HEPA - Hepion Pharma completes final dosing in multiple ascending dose study of CRV431

Hepion Pharmaceuticals (NASDAQ: HEPA ) announces that dosing has been completed in all subjects enrolled in the Phase 1b multiple ascending dose (MAD) study of CRV431. More news on: Hepion Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

Previous 10 Next 10